Proprietary Technology Platform for Delivery of Drugs to the Liver

Ligand's LTP™ technology is a broad, second-generation liver-targeting prodrug technology that has an activation mechanism similar to HepDirect but with broader applications and many improved features. The proprietary chemical modifications can be used with many chemical classes of drugs in addition to phosphorus-containing compounds, and have multiple chemistry strategies, improving flexibility and success rates. In addition, the second-generation technology eliminates the formation of undesirable by-products that may occur with other targeting technologies.

Learn More